The desire to stop sleep apnea now is understandable — it is a condition that affects every waking hour through the damage it does to every sleeping one. But the range of treatments available, and the range of claims made about them, can make it difficult to know where to start or what to trust. This guide works through the major treatment categories in order of evidence strength, with honest assessments of what each approach can realistically deliver and for whom it is most appropriate.
CPAP — The Benchmark Treatment
Continuous positive airway pressure remains the most comprehensively studied and most consistently effective treatment for obstructive sleep apnea across all severity levels. Its mechanism is straightforward and reliable: a pneumatic splint of pressurized air prevents airway collapse regardless of the underlying anatomical or physiological cause. When used consistently, CPAP reduces AHI to near-normal levels in the large majority of patients, and the evidence linking consistent CPAP use to improvements in daytime sleepiness, blood pressure, cardiovascular risk, cognitive function, and mood is the strongest in sleep medicine.
The limitation of CPAP is not efficacy — it is adherence. Real-world adherence studies consistently find that roughly half of patients do not use CPAP consistently enough to capture its full benefit over the long term. The adjustment period is genuine, mask fit problems are common, and the psychological barrier of sleeping with equipment every night is real for many patients. These are solvable problems in most cases — with the right mask, the right support, and persistence through the first few weeks — but they are the primary reason that alternatives have clinical value even when they are less efficacious than CPAP.
Oral Appliance Therapy
Mandibular advancement devices — custom-fitted oral appliances that reposition the lower jaw forward during sleep — are the most evidence-supported alternative to CPAP for mild to moderate obstructive sleep apnea and for patients who are CPAP-intolerant regardless of severity. They work by increasing the posterior airway space, reducing the gravitational load on the tongue base, and improving airway patency without requiring a mask or pressurized air.
The evidence for oral appliances is substantial. Multiple randomized controlled trials have demonstrated meaningful reductions in AHI, improvements in daytime sleepiness, and reductions in blood pressure with mandibular advancement device therapy. The average AHI reduction is generally less than what CPAP achieves in head-to-head comparisons, but real-world outcomes in some studies are comparable because oral appliance adherence tends to be higher than CPAP adherence — a less efficacious treatment used consistently can produce better health outcomes than a more efficacious one used intermittently.
Oral appliances require a dental evaluation, custom fabrication by a dentist experienced in sleep medicine, and a period of titration to find the optimal jaw advancement position. They are not appropriate as a primary treatment for severe sleep apnea where the AHI reduction they produce is insufficient, though they can be used as adjuncts.
Positional Therapy
For patients with positional obstructive sleep apnea — defined as supine AHI at least double the lateral AHI — positional therapy is a legitimate primary or adjunct treatment option with a meaningful evidence base. Keeping the airway in a geometrically favorable position by avoiding supine sleep removes the primary driver of events in this subgroup.
Purpose-built positional devices that use vibrotactile feedback to discourage back sleeping have performed well in clinical trials, with AHI reductions in positional patients that in some studies approach those achieved with CPAP. Simpler approaches — positional pillows, body pillows, or the tennis ball technique — are less well studied but effective for motivated patients in reducing supine sleep time.
Positional therapy is not appropriate as a primary treatment for patients whose apnea is severe in all positions, but it is consistently underutilized as an adjunct for CPAP users with a strong positional component to their residual events.
Weight Loss
The relationship between body weight and sleep apnea severity is among the most robustly documented in sleep medicine. Weight loss of 10% to 15% of body weight produces meaningful reductions in AHI — in some studies sufficient to move patients across severity thresholds or to subclinical levels. For patients who are overweight or obese, weight loss is the intervention with the greatest potential to modify the underlying cause rather than compensating for it.
The evidence for surgical weight loss — bariatric surgery — is the strongest, with multiple studies documenting substantial AHI reductions following significant surgical weight loss. Lifestyle-based weight loss produces more modest average results, partly because the magnitude of weight loss achieved is typically smaller and partly because individual variation in response is high. Some patients achieve dramatic AHI reductions with relatively modest weight loss; others lose significant weight with minimal impact on their apnea.
Weight loss is almost never sufficient as a standalone treatment for moderate to severe sleep apnea in the short term, but it is an important long-term strategy that may reduce treatment requirements over time and improve overall health outcomes independently of the sleep apnea benefit.
Surgical Options
Upper airway surgery encompasses a wide range of procedures targeting different anatomical sites — uvulopalatopharyngoplasty targeting the soft palate, tonsillectomy for tonsillar hypertrophy, nasal procedures for obstruction, tongue base reduction, and maxillomandibular advancement for craniofacial contributors. Outcomes vary considerably by procedure and patient selection.
Hypoglossal nerve stimulation — a device-based therapy that electrically activates the nerve controlling the tongue during sleep, preventing posterior displacement — has the strongest recent evidence among surgical approaches for patients who cannot tolerate CPAP and have appropriate anatomy. It is not a first-line treatment and has specific eligibility criteria, but for carefully selected patients it produces clinically significant and durable AHI reductions.
The key principle across surgical options is patient selection. Procedures targeted at the site of obstruction identified through careful anatomical evaluation, including drug-induced sleep endoscopy where appropriate, produce better outcomes than procedures applied without anatomical characterization of where the collapse is occurring.
Myofunctional Therapy
Oropharyngeal exercises — a set of tongue, soft palate, and facial muscle exercises collectively referred to as myofunctional therapy — have emerged as an evidence-supported adjunct treatment for sleep apnea, particularly mild to moderate disease. A meta-analysis of randomized controlled trials found meaningful average reductions in AHI and improvements in oxygen desaturation with myofunctional therapy compared to control conditions.
The proposed mechanism is strengthening of the upper airway musculature, reducing its collapsibility during the muscle relaxation of sleep. Myofunctional therapy carries no side effects, requires no equipment, and can be practiced independently once the exercises are learned. It is not sufficient as a standalone treatment for moderate to severe apnea, but it is a reasonable adjunct that requires minimal resources and has reasonable evidence supporting its use.
Matching Treatment to Patient
The evidence does not support a single universal answer to stopping sleep apnea — it supports matching treatment to the individual based on severity, anatomy, comorbidities, patient preference, and adherence likelihood. For most patients with moderate to severe apnea, CPAP with strong support for adherence is the starting point. For those who cannot tolerate it, oral appliances and hypoglossal nerve stimulation offer evidence-supported alternatives. Positional therapy, weight loss, and myofunctional therapy strengthen outcomes as adjuncts across most treatment approaches and in some mild positional cases can be primary strategies. The goal is not the theoretically optimal treatment — it is the most effective treatment the patient will actually use consistently.